This inventor holds 1 USPTO granted patent. Top assignee: Oxford University Innovation Ltd. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Andrew Pannifer: Innovator in Bacterial Infection Treatment
Introduction
Andrew Pannifer is a notable inventor based in Newhouse, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target bacterial infections. His work focuses on innovative solutions to combat antibiotic resistance.
Latest Patents
Andrew Pannifer holds 1 patent for his invention titled "Inhibitors of metallo-beta-lactamases." This patent relates to specific compounds, particularly indole derivatives, that serve as inhibitors of bacterial metallo-beta-lactamases. The invention also encompasses processes for preparing these compounds, pharmaceutical compositions that include them, and their application in treating bacterial infections.
Career Highlights
Pannifer is associated with Oxford University Innovation Ltd, where he continues to advance his research and development efforts. His work is crucial in addressing the growing challenge of antibiotic resistance, making him a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Andrew has collaborated with esteemed colleagues such as Jürgen Brem and Christopher Joseph Schofield. These partnerships have enhanced his research and contributed to the success of his innovations.
Conclusion
Andrew Pannifer's contributions to the field of pharmaceutical sciences highlight his commitment to developing effective treatments for bacterial infections. His innovative work continues to pave the way for advancements in medical research and public health.